CA2855971C - Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma - Google Patents

Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma Download PDF

Info

Publication number
CA2855971C
CA2855971C CA2855971A CA2855971A CA2855971C CA 2855971 C CA2855971 C CA 2855971C CA 2855971 A CA2855971 A CA 2855971A CA 2855971 A CA2855971 A CA 2855971A CA 2855971 C CA2855971 C CA 2855971C
Authority
CA
Canada
Prior art keywords
head
cell carcinoma
squamous cell
neck squamous
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2855971A
Other languages
English (en)
French (fr)
Other versions
CA2855971A1 (en
Inventor
Elizabeth Franzmann
Lutecia PEREIRA
Isildinha M. Reis
Robert C. Duncan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Miami
Original Assignee
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Miami filed Critical University of Miami
Publication of CA2855971A1 publication Critical patent/CA2855971A1/en
Application granted granted Critical
Publication of CA2855971C publication Critical patent/CA2855971C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70585—CD44
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
CA2855971A 2011-11-15 2012-11-15 Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma Expired - Fee Related CA2855971C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161559974P 2011-11-15 2011-11-15
US61/559,974 2011-11-15
US201261654595P 2012-06-01 2012-06-01
US61/654,595 2012-06-01
PCT/US2012/065282 WO2013074793A1 (en) 2011-11-15 2012-11-15 Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Publications (2)

Publication Number Publication Date
CA2855971A1 CA2855971A1 (en) 2013-05-23
CA2855971C true CA2855971C (en) 2022-01-04

Family

ID=48430146

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2855971A Expired - Fee Related CA2855971C (en) 2011-11-15 2012-11-15 Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Country Status (13)

Country Link
US (3) US20140329230A1 (enExample)
EP (1) EP2780714B1 (enExample)
JP (1) JP6174035B2 (enExample)
CN (1) CN104067126B (enExample)
AU (3) AU2012340441A1 (enExample)
BR (1) BR112014011563B1 (enExample)
CA (1) CA2855971C (enExample)
CO (1) CO6980621A2 (enExample)
ES (1) ES2640532T3 (enExample)
IL (1) IL232556A (enExample)
MX (1) MX352642B (enExample)
PE (1) PE20141565A1 (enExample)
WO (1) WO2013074793A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6174035B2 (ja) 2011-11-15 2017-08-02 ユニヴァーシティ・オヴ・マイアミ ヒトパピローマウイルスを検出し頭頸部扁平上皮癌を予後予測する方法
JP2016527514A (ja) * 2013-07-31 2016-09-08 ユニバーシティー オブ マイアミ 対象の癌リスクを明らかにするための組成物及び方法
US20160208346A1 (en) * 2013-08-19 2016-07-21 Notre Dame Du Lac Method and composition for detection of oncogenic hpv
US10247720B2 (en) 2014-05-22 2019-04-02 University Of Notre Dame Du Lac Integrated membrane sensor for rapid molecular detection
US11268153B2 (en) 2015-06-22 2022-03-08 The Johns Hopkins University Head and neck squamous cell carcinoma assays
JP6655243B2 (ja) * 2015-09-01 2020-02-26 国立大学法人 鹿児島大学 口腔前癌病変の検出方法
CN107092854B (zh) * 2016-02-18 2020-05-22 财团法人金属工业研究发展中心 检测细胞受人类乳头瘤病毒(hpv)感染的装置及其检测方法
GB201808839D0 (en) 2018-05-30 2018-07-11 Cancer Research Tech Ltd Method of predicting survival rates for cancer patients
WO2020018954A1 (en) * 2018-07-20 2020-01-23 Predentome, Inc. Methods and systems for oral microbiome analysis
EP3930834A4 (en) * 2019-02-26 2023-01-04 University of Miami Device for methods of detecting cancer
US20240188897A1 (en) * 2021-04-23 2024-06-13 The University Of Chicago Machine learning based histopathological recurrence prediction models for hpv+ head / neck squamous cell carcinoma
EP4605748A1 (en) * 2022-10-17 2025-08-27 Vigilant Biosciences, Inc. Methods and compositions for oral cancer risk

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403551A (en) 1993-09-16 1995-04-04 Roche Diagnostic Systems, Inc. Assaying device and container for in field analysis of a specimen and later shipment of the unadulterated specimen
US6235470B1 (en) 1993-11-12 2001-05-22 The Johns Hopkins University School Of Medicine Detection of neoplasia by analysis of saliva
US5990299A (en) * 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
US5976895A (en) 1996-03-11 1999-11-02 American Biomedica Corporation Device for the collection, testing and shipment of body fluid samples
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US6379620B1 (en) 1998-11-16 2002-04-30 Barry M. Tydings Assaying device and method for in field urinalysis
US6294349B1 (en) 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
US7189397B2 (en) 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20040029114A1 (en) 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
DE60300339T2 (de) * 2003-08-25 2006-04-13 Mtm Laboratories Ag Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
JP4563186B2 (ja) 2004-02-16 2010-10-13 理研ビタミン株式会社 耐熱性が改善されたアントシアニン色素
US20050214880A1 (en) * 2004-03-26 2005-09-29 University Of Miami Salivary soluble CD44: a molecular marker for head and neck cancer
WO2007129999A2 (en) 2004-07-14 2007-11-15 Biospectrum, Inc. Antiproliferative peptides and antibodies for their detection
BRPI0619712A2 (pt) 2005-11-10 2011-10-11 Univ Kentucky dispositivo para a identificação de um paciente como um candidato para testes radiográficos para o cáncer do pulmão, composição para detectar radiograficamente um cáncer do pulmão de estágio adiantado, dispositivo para o ensaio do cáncer do pulmão, uso de um painel, e, dispositivo de diagnóstico para a detecção do cáncer do pulmão
US8088591B2 (en) 2006-05-12 2012-01-03 University Of Miami Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
CN101230390A (zh) * 2007-12-07 2008-07-30 湖北大学 一种用于妇科恶性肿瘤早期筛选的基因芯片及其检测方法
US8715926B2 (en) * 2008-11-24 2014-05-06 Loma Linda University Biomarkers for the detection of head and neck tumors
JP6174035B2 (ja) 2011-11-15 2017-08-02 ユニヴァーシティ・オヴ・マイアミ ヒトパピローマウイルスを検出し頭頸部扁平上皮癌を予後予測する方法

Also Published As

Publication number Publication date
AU2012340441A1 (en) 2014-05-29
AU2020277155A1 (en) 2020-12-24
BR112014011563A2 (pt) 2017-05-09
BR112014011563B1 (pt) 2022-05-24
MX2014005887A (es) 2014-09-08
CA2855971A1 (en) 2013-05-23
CN104067126B (zh) 2017-04-12
EP2780714A4 (en) 2015-07-15
US10180430B2 (en) 2019-01-15
ES2640532T3 (es) 2017-11-03
CO6980621A2 (es) 2014-06-27
WO2013074793A1 (en) 2013-05-23
AU2018203361B2 (en) 2020-08-27
AU2018203361A1 (en) 2018-05-31
EP2780714A1 (en) 2014-09-24
US20160305942A1 (en) 2016-10-20
JP6174035B2 (ja) 2017-08-02
IL232556A (en) 2017-12-31
CN104067126A (zh) 2014-09-24
PE20141565A1 (es) 2014-10-25
IL232556A0 (en) 2014-06-30
US20140329230A1 (en) 2014-11-06
EP2780714B1 (en) 2017-08-16
JP2014533372A (ja) 2014-12-11
MX352642B (es) 2017-12-01
US10180431B2 (en) 2019-01-15
US20150219656A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
CA2855971C (en) Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
WO2011160015A3 (en) Rotors for immunoassays
WO2010053587A3 (en) Methods of monitoring conditions by sequence analysis
WO2010002911A3 (en) Methods and materials for monitoring myeloma using quantitative mass spetrometry
WO2014153099A3 (en) Method for using exhaled breath to determine the presence of drug
EP2566983A4 (en) SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE
WO2012097081A3 (en) Protein detection method
WO2009134944A3 (en) Methods of determining the health status of an individual
WO2011008581A3 (en) Devices, methods, and kits for determining analyte concentrations
WO2010039809A3 (en) Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
WO2014143977A3 (en) Biomarkers and methods for predicting preeclampsia
WO2009151628A3 (en) Monitoring tcr-b to determine hiv therapy and disease progression
WO2013062515A3 (en) Lung cancer biomarkers and uses thereof
WO2012044871A3 (en) Diagnostic device and method for sensing hydration state of a mammallian subject
JP2014533372A5 (enExample)
WO2014074835A3 (en) Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone
MX2014006118A (es) Deteccion de analitos.
WO2013153461A3 (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases
WO2012032345A3 (en) Biomarker signatures and uses thereof
WO2011119163A8 (en) Method and system for analyzing a blood sample
WO2009020782A3 (en) Oral fluid assays for the detection of heavy metal exposure
WO2012025637A9 (en) An agglutination assay method and device
GB2494580A (en) Method for diagnosing lung cancer
WO2012139052A3 (en) Antibody biomarkers for diabetes

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170830

MKLA Lapsed

Effective date: 20221115